Will nirsevimab be the holy grail for prevention of respiratory syncytial virus lower respiratory tract infections in infants?
@article{TP122378,
author = {Nusrat Homaira},
title = {Will nirsevimab be the holy grail for prevention of respiratory syncytial virus lower respiratory tract infections in infants?},
journal = {Translational Pediatrics},
volume = {13},
number = {3},
year = {2024},
keywords = {},
abstract = {},
issn = {2224-4344}, url = {https://tp.amegroups.org/article/view/122378}
}